Table 3.
Characteristic (%) | Total (N=100) | Explained (N=48) | Unexplained (N=52) | P Value |
---|---|---|---|---|
Cardiovascular Diseases | ||||
Coronary Artery Disease | 13 (13.0) | 5 (10.4) | 8 (15.4) | NS |
Arterial Hypertension | 35 (35.0) | 15 (31.3) | 20 (38.5) | NS |
Congestive Heart Failure | 4 (4.0) | 3 (6.3) | 1 (1.9) | NS |
Other Cardiovascular Diseases | 5 (5.0) | 1 (2.1) | 4 (7.7) | NS |
Metabolic Disorders | ||||
Dyslipidemia | 26 (26.0) | 7 (14.6) | 19 (36.5) | 0.012 |
Diabetes | 23 (23.0) | 7 (14.6) | 16 (30.8) | 0.054 |
Diabetes and Dyslipidemia | 11 (11.0) | 1(2.1) | 10 19.2) | 0.006 |
Hypertension and Dyslipidemia | 17 (17.0) | 5 (10.4) | 12 (23.1) | NS |
Cerebrovascular Disease | 2 (2.0) | 0 (0.0) | 2 (3.8) | NS |
Bronchial Asthma or COPDb | 7 (7.0) | 3 (6.3) | 4 (7.7) | NS |
Obstructive Sleep Apnea | 2 (2.0) | 0 (0.0) | 2 (3.8) | NS |
=Coronary artery disease, diabetes, ischemic cerebrovascular events, peripheral arterial insufficiency;
=Chronic obstructive pulmonary disease